Selected research
Market Structure
Global Tag Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Tag Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tag Antibody include Sino Biological, GenScript, Sino Biological, Santa Cruz Biotechnology, R&D Systems, OriGene, Novus Biologicals, Nacalai USA and Merck Millipore, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Tag Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Tag Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Tag Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tag Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.
Tag Antibody Segment by Company
Sino Biological
GenScript
Sino Biological
Santa Cruz Biotechnology
R&D Systems
OriGene
Novus Biologicals
Nacalai USA
Merck Millipore
GeneTex
Fortis Life Sciences
EpigenTek
Creative Diagnostics
Bio-Techne
Bio-Rad Antibodies
BiologicsCorp
Bio X Cell
Applied Biological Materials
Agrisera antibodies
Abcam
Tag Antibody Segment by Type
His Tag Antibody
HA Tag Antibody
Other
Tag Antibody Segment by Application
Western Blot
Flow Cytometry
Immune Precipitation
Immuno Fluorescence
Other
Tag Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tag Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tag Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tag Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Tag Antibody market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tag Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tag Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Tag Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- His Tag Antibody
- HA Tag Antibody
- Other
Applications
- Western Blot
- Flow Cytometry
- Immune Precipitation
- Immuno Fluorescence
- Other
Companies covered
- Sino Biological
- GenScript
- Sino Biological
- Santa Cruz Biotechnology
- R&D Systems
- OriGene
- Novus Biologicals
- Nacalai USA
- Merck Millipore
- GeneTex
- Fortis Life Sciences
- EpigenTek
- Creative Diagnostics
- Bio-Techne
- Bio-Rad Antibodies
- BiologicsCorp
- Bio X Cell
- Applied Biological Materials
- Agrisera antibodies
- Abcam
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Tag Antibody Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Tag Antibody Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Tag Antibody Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Tag Antibody Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Tag Antibody Market Dynamics
- 2.1 Tag Antibody Industry Trends
- 2.2 Tag Antibody Industry Drivers
- 2.3 Tag Antibody Industry Opportunities and Challenges
- 2.4 Tag Antibody Industry Restraints
3 Tag Antibody Market by Manufacturers
- 3.1 Global Tag Antibody Revenue by Manufacturers (2021-2026)
- 3.2 Global Tag Antibody Sales by Manufacturers (2021-2026)
- 3.3 Global Tag Antibody Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Tag Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Tag Antibody Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Tag Antibody Manufacturers, Product Type & Application
- 3.7 Global Tag Antibody Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Tag Antibody Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Tag Antibody Players Market Share by Revenue in 2025
- 3.8.3 2025 Tag Antibody Tier 1, Tier 2, and Tier 3
4 Tag Antibody Market by Type
- 4.1 Tag Antibody Type Introduction
- 4.1.1 His Tag Antibody
- 4.1.2 HA Tag Antibody
- 4.1.3 Other
- 4.2 Global Tag Antibody Sales by Type
- 4.2.1 Global Tag Antibody Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Tag Antibody Sales by Type (2021-2032)
- 4.2.3 Global Tag Antibody Sales Market Share by Type (2021-2032)
- 4.3 Global Tag Antibody Revenue by Type
- 4.3.1 Global Tag Antibody Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Tag Antibody Revenue by Type (2021-2032)
- 4.3.3 Global Tag Antibody Revenue Market Share by Type (2021-2032)
5 Tag Antibody Market by Application
- 5.1 Tag Antibody Application Introduction
- 5.1.1 Western Blot
- 5.1.2 Flow Cytometry
- 5.1.3 Immune Precipitation
- 5.1.4 Immuno Fluorescence
- 5.1.5 Other
- 5.2 Global Tag Antibody Sales by Application
- 5.2.1 Global Tag Antibody Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Tag Antibody Sales by Application (2021-2032)
- 5.2.3 Global Tag Antibody Sales Market Share by Application (2021-2032)
- 5.3 Global Tag Antibody Revenue by Application
- 5.3.1 Global Tag Antibody Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Tag Antibody Revenue by Application (2021-2032)
- 5.3.3 Global Tag Antibody Revenue Market Share by Application (2021-2032)
6 Global Tag Antibody Sales by Region
- 6.1 Global Tag Antibody Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Tag Antibody Sales by Region (2021-2032)
- 6.2.1 Global Tag Antibody Sales by Region (2021-2026)
- 6.2.2 Global Tag Antibody Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Tag Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Tag Antibody Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Tag Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Tag Antibody Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Tag Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Tag Antibody Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Tag Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Tag Antibody Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Tag Antibody Revenue by Region
- 7.1 Global Tag Antibody Revenue by Region
- 7.1.1 Global Tag Antibody Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Tag Antibody Revenue by Region (2021-2026)
- 7.1.3 Global Tag Antibody Revenue by Region (2027-2032)
- 7.1.4 Global Tag Antibody Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Tag Antibody Revenue (2021-2032)
- 7.2.2 North America Tag Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Tag Antibody Revenue (2021-2032)
- 7.3.2 Europe Tag Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Tag Antibody Revenue (2021-2032)
- 7.4.2 Asia-Pacific Tag Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Tag Antibody Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Tag Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sino Biological
- 8.1.1 Sino Biological Company Information
- 8.1.2 Sino Biological Business Overview
- 8.1.3 Sino Biological Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sino Biological Tag Antibody Product Portfolio
- 8.1.5 Sino Biological Recent Developments
- 8.2 GenScript
- 8.2.1 GenScript Company Information
- 8.2.2 GenScript Business Overview
- 8.2.3 GenScript Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 GenScript Tag Antibody Product Portfolio
- 8.2.5 GenScript Recent Developments
- 8.3 Sino Biological
- 8.3.1 Sino Biological Company Information
- 8.3.2 Sino Biological Business Overview
- 8.3.3 Sino Biological Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sino Biological Tag Antibody Product Portfolio
- 8.3.5 Sino Biological Recent Developments
- 8.4 Santa Cruz Biotechnology
- 8.4.1 Santa Cruz Biotechnology Company Information
- 8.4.2 Santa Cruz Biotechnology Business Overview
- 8.4.3 Santa Cruz Biotechnology Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Santa Cruz Biotechnology Tag Antibody Product Portfolio
- 8.4.5 Santa Cruz Biotechnology Recent Developments
- 8.5 R&D Systems
- 8.5.1 R&D Systems Company Information
- 8.5.2 R&D Systems Business Overview
- 8.5.3 R&D Systems Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 R&D Systems Tag Antibody Product Portfolio
- 8.5.5 R&D Systems Recent Developments
- 8.6 OriGene
- 8.6.1 OriGene Company Information
- 8.6.2 OriGene Business Overview
- 8.6.3 OriGene Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 OriGene Tag Antibody Product Portfolio
- 8.6.5 OriGene Recent Developments
- 8.7 Novus Biologicals
- 8.7.1 Novus Biologicals Company Information
- 8.7.2 Novus Biologicals Business Overview
- 8.7.3 Novus Biologicals Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Novus Biologicals Tag Antibody Product Portfolio
- 8.7.5 Novus Biologicals Recent Developments
- 8.8 Nacalai USA
- 8.8.1 Nacalai USA Company Information
- 8.8.2 Nacalai USA Business Overview
- 8.8.3 Nacalai USA Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Nacalai USA Tag Antibody Product Portfolio
- 8.8.5 Nacalai USA Recent Developments
- 8.9 Merck Millipore
- 8.9.1 Merck Millipore Company Information
- 8.9.2 Merck Millipore Business Overview
- 8.9.3 Merck Millipore Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Merck Millipore Tag Antibody Product Portfolio
- 8.9.5 Merck Millipore Recent Developments
- 8.10 GeneTex
- 8.10.1 GeneTex Company Information
- 8.10.2 GeneTex Business Overview
- 8.10.3 GeneTex Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 GeneTex Tag Antibody Product Portfolio
- 8.10.5 GeneTex Recent Developments
- 8.11 Fortis Life Sciences
- 8.11.1 Fortis Life Sciences Company Information
- 8.11.2 Fortis Life Sciences Business Overview
- 8.11.3 Fortis Life Sciences Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Fortis Life Sciences Tag Antibody Product Portfolio
- 8.11.5 Fortis Life Sciences Recent Developments
- 8.12 EpigenTek
- 8.12.1 EpigenTek Company Information
- 8.12.2 EpigenTek Business Overview
- 8.12.3 EpigenTek Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 EpigenTek Tag Antibody Product Portfolio
- 8.12.5 EpigenTek Recent Developments
- 8.13 Creative Diagnostics
- 8.13.1 Creative Diagnostics Company Information
- 8.13.2 Creative Diagnostics Business Overview
- 8.13.3 Creative Diagnostics Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Creative Diagnostics Tag Antibody Product Portfolio
- 8.13.5 Creative Diagnostics Recent Developments
- 8.14 Bio-Techne
- 8.14.1 Bio-Techne Company Information
- 8.14.2 Bio-Techne Business Overview
- 8.14.3 Bio-Techne Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Bio-Techne Tag Antibody Product Portfolio
- 8.14.5 Bio-Techne Recent Developments
- 8.15 Bio-Rad Antibodies
- 8.15.1 Bio-Rad Antibodies Company Information
- 8.15.2 Bio-Rad Antibodies Business Overview
- 8.15.3 Bio-Rad Antibodies Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Bio-Rad Antibodies Tag Antibody Product Portfolio
- 8.15.5 Bio-Rad Antibodies Recent Developments
- 8.16 BiologicsCorp
- 8.16.1 BiologicsCorp Company Information
- 8.16.2 BiologicsCorp Business Overview
- 8.16.3 BiologicsCorp Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 BiologicsCorp Tag Antibody Product Portfolio
- 8.16.5 BiologicsCorp Recent Developments
- 8.17 Bio X Cell
- 8.17.1 Bio X Cell Company Information
- 8.17.2 Bio X Cell Business Overview
- 8.17.3 Bio X Cell Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Bio X Cell Tag Antibody Product Portfolio
- 8.17.5 Bio X Cell Recent Developments
- 8.18 Applied Biological Materials
- 8.18.1 Applied Biological Materials Company Information
- 8.18.2 Applied Biological Materials Business Overview
- 8.18.3 Applied Biological Materials Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Applied Biological Materials Tag Antibody Product Portfolio
- 8.18.5 Applied Biological Materials Recent Developments
- 8.19 Agrisera antibodies
- 8.19.1 Agrisera antibodies Company Information
- 8.19.2 Agrisera antibodies Business Overview
- 8.19.3 Agrisera antibodies Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Agrisera antibodies Tag Antibody Product Portfolio
- 8.19.5 Agrisera antibodies Recent Developments
- 8.20 Abcam
- 8.20.1 Abcam Company Information
- 8.20.2 Abcam Business Overview
- 8.20.3 Abcam Tag Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Abcam Tag Antibody Product Portfolio
- 8.20.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Tag Antibody Value Chain Analysis
- 9.1.1 Tag Antibody Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Tag Antibody Production Mode & Process
- 9.2 Tag Antibody Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Tag Antibody Distributors
- 9.2.3 Tag Antibody Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst